AU497577B2 - Clavulanic acid derivatives - Google Patents

Clavulanic acid derivatives

Info

Publication number
AU497577B2
AU497577B2 AU13020/76A AU1302076A AU497577B2 AU 497577 B2 AU497577 B2 AU 497577B2 AU 13020/76 A AU13020/76 A AU 13020/76A AU 1302076 A AU1302076 A AU 1302076A AU 497577 B2 AU497577 B2 AU 497577B2
Authority
AU
Australia
Prior art keywords
acid derivatives
clavulanic acid
clavulanic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU13020/76A
Other languages
English (en)
Other versions
AU1302076A (en
Inventor
T. T. Goodacre J. & Ponsford R. J Howarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB15209/75A external-priority patent/GB1545467A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU1302076A publication Critical patent/AU1302076A/en
Application granted granted Critical
Publication of AU497577B2 publication Critical patent/AU497577B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02Preparation
    • C07D503/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU13020/76A 1975-04-14 1976-04-14 Clavulanic acid derivatives Expired AU497577B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof
GBGB15209/75 1975-04-14
GBGB39671/75 1975-09-27
GB3967175 1975-09-27

Publications (2)

Publication Number Publication Date
AU1302076A AU1302076A (en) 1977-10-20
AU497577B2 true AU497577B2 (en) 1978-12-21

Family

ID=26251136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13020/76A Expired AU497577B2 (en) 1975-04-14 1976-04-14 Clavulanic acid derivatives

Country Status (22)

Country Link
JP (1) JPS51127093A (xx)
AR (1) AR208773A1 (xx)
AT (1) AT342199B (xx)
AU (1) AU497577B2 (xx)
CA (1) CA1074802A (xx)
CH (1) CH602742A5 (xx)
DE (1) DE2616088A1 (xx)
DK (1) DK144066C (xx)
ES (1) ES446468A1 (xx)
FI (1) FI760946A (xx)
FR (1) FR2336130A1 (xx)
GR (1) GR58256B (xx)
HU (1) HU175444B (xx)
IE (1) IE42666B1 (xx)
IL (1) IL49279A (xx)
LU (1) LU74749A1 (xx)
MX (1) MX3453E (xx)
NL (1) NL7603840A (xx)
NO (1) NO761241L (xx)
PT (1) PT64897B (xx)
SE (1) SE427037B (xx)
YU (1) YU69476A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5359690A (en) * 1976-09-09 1978-05-29 Glaxo Lab Ltd Production of novel betaa lactam
AT363181B (de) * 1976-10-25 1981-07-10 Glaxo Lab Ltd Verfahren zur herstellung von neuen clavulansaeurederivaten
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition

Also Published As

Publication number Publication date
ES446468A1 (es) 1977-11-01
FR2336130B1 (xx) 1979-06-22
IE42666L (en) 1976-10-14
LU74749A1 (xx) 1976-11-11
AT342199B (de) 1978-03-28
CH602742A5 (xx) 1978-07-31
SE427037B (sv) 1983-02-28
YU69476A (en) 1982-05-31
MX3453E (es) 1980-12-03
SE7604287L (sv) 1976-10-15
NO761241L (xx) 1976-10-15
FR2336130A1 (fr) 1977-07-22
PT64897A (en) 1976-04-01
DK156576A (da) 1976-10-15
IL49279A0 (en) 1976-06-30
DK144066C (da) 1982-05-10
AU1302076A (en) 1977-10-20
JPS51127093A (en) 1976-11-05
NL7603840A (nl) 1976-10-18
IL49279A (en) 1979-05-31
FI760946A (xx) 1976-10-15
HU175444B (hu) 1980-08-28
GR58256B (en) 1977-09-15
PT64897B (en) 1977-08-18
DK144066B (da) 1981-11-30
CA1074802A (en) 1980-04-01
DE2616088A1 (de) 1976-10-28
ATA215576A (de) 1977-07-15
IE42666B1 (en) 1980-09-24
AR208773A1 (es) 1977-02-28

Similar Documents

Publication Publication Date Title
AU511853B2 (en) l-Phenyl-2-Oxo-Pyrroliaine-4-carboxylic acid derivatives
AU1762976A (en) Northropine benziate derivatives
AU1740876A (en) 2-aroyl-3-phenylbenzothiophene derivatives
AU503489B2 (en) Substituted aminodeoxy clavulanic acid
AU503529B2 (en) Clavulanic acid
AU501066B2 (en) Fudidic acid derivatives
AU509313B2 (en) Clavulanic acid
AU497932B2 (en) Phenoxyalkylcarboxylic acid derivatives
AU500761B2 (en) Phenoxyalkylcarboxylic acid derivatives
AU1434876A (en) Eburnamenine derivatives
AU515736B2 (en) Clavulanic acid derivatives
AU1759676A (en) Bensisoxazole derivatives
KE3292A (en) Clavulanic acid derivatives
AU1633476A (en) Homophthalimide derivatives
AU1547576A (en) 5-fluoropyrimidin-4-one derivatives
AU517920B2 (en) Clavulanic acid derivatives
AU1855676A (en) Clavulanic acid derivatives
GB1547169A (en) Clavulanic acid derivatives
AU1651576A (en) Thiaxanthene derivatives
AU1491776A (en) Benzocyclopheptathiophene derivatives
AU1577376A (en) 3-hydroxy-pyrio-2-thione derivatives
AU500980B2 (en) Oxanilic acid derivatives
AU497577B2 (en) Clavulanic acid derivatives
AU519232B2 (en) Clavulanic acid derivatives
GB1542405A (en) Clavulanic acid derivatives